Rachel Cooney

Has grant

Honorary Senior Lecturer

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rachel Cooney is an Honorary Senior Lecturer at the University of Birmingham, UK. Her research areas focus on inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, with recent publications addressing disability assessment, treatment efficacy, and guidelines in IBD management. Cooney’s work emphasizes real-world effectiveness studies and innovative treatment approaches in gastroenterology.

Recent Grants

Grant: Open

Optimisation before Crohn’s surgery using Exclusive enteral Nutrition (OCEaN study)

Open Date: 2022-05-01

Close Date: 2026-10-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (8)

Glen Doherty

UCD Full Clinical Professor

Dublin City University

IRELAND

View details

Animesh Acharjee

University of Birmingham

UNITED KINGDOM

View details

Shahida Din

University of Edinburgh

UNITED KINGDOM

View details

Thomas Butler

The University of Manchester

UNITED KINGDOM

View details

Anna Rowe

University of Birmingham

UNITED KINGDOM

View details

Vassiliki Sinopoulou

University of Central Lancashire

UNITED KINGDOM

View details

Gordon Moran

University of Nottingham

UNITED KINGDOM

View details

Professor Laith Alrubaiy

Swansea University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rachel Cooney

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025.

Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial.

FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial.

The IBD-disk accurately assesses disability and psychological burden at IBD diagnosis and predicts adverse outcomes in both UC and Crohn’s disease during the first year of treatment: a prospective observational cohort study

Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-Centre UK study

A Low Dietary Quality Index in a Newly Diagnosed Inflammatory Bowel Disease Cohort: Results from a Case—Control Study

Preoperative Optimization for Elective Surgery in Crohn’s Disease: A Narrative Review

Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures.

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres.

Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015–2027): a nationwide, population-based study

Collaborators (8)

Glen Doherty

Animesh Acharjee

Shahida Din

Thomas Butler

Anna Rowe

Vassiliki Sinopoulou

Gordon Moran

Professor Laith Alrubaiy

Make your next move.